Thomas, T.; Richards, C.J.; de Caestecker, J.; Robinson, R.J.
April 2003
Gut;Apr2003 Supplement 1, Vol. 52, pA32
Academic Journal
Background: Management of HGD in Barrett's remains controversial. Aim: To review management and outcome of HGD from three hospitals in one district. Methods: Case record study. Patients with dysplasia identified from pathology database. All HGD verified by at least two upper Gl pathologists and those with coincident adenocarcinoma (AC) with HGD excluded. Results: 99 cases of dysplasia identified; 36 had HGD arising in Barrett's mucosa, M/F 31/5, mean age 67 (range 34-95). 9/36 (25%) were identified during Barrett's surveillence. 7 had no further interventions due to age and comorbidity. On repeat endoscopy and biopsy of the remaining 29 (usually within 3 months), 9 had intramucosal AC and are not further considered. Of the remaining 20, 16 had persisting HGD and 4 became and remained negative for dysplasia (mean follow up 17.2 months). Of the 16 with persisting HGD, 8 had oesophagectomy of which 6 had AC on operative histology. At a mean follow up of 18.7 months, 6 patients were disease free. There were no immediate (30 day) postoperative deaths; 3 died (2-47 months after surgery), 2 of unrelated causes and one of metastatic AC. 5 were treated with argon ablation of which 2 had nodules and/or ulcers in the Barrett's segment. In 4/5 the Barrett's segment was ablated; absence of HGD was confirmed histologically in 2 (both originally had HGD in "flat" mucosa) who remained disease free (mean FU 10 months); 2/5 developed metastatic AC of whom 1 has died. The final 3/16 continued to have surveillance: 2 developed AC (I death) and 1 died of an unrelated cause. In summary: 15 of 36 (42%) of patients with biopsy proven HGD, have underlying AC either on resection or on early rebiopsy. A further 4 developed AC during surveillance (median 17 months, range 4-64). A small proportion of HGD regress (4/36-11%). Conclusions: Oesophagectomy remains the treatment of choice in HGD because a high proportion have coincident AC. Argon ablation can be effective in a proportion of...


Related Articles

  • Endoscopic Resection for Barrett's High-Grade Dysplasia and Early Esophageal Adenocarcinoma: An Essential Staging Procedure With Long-Term Therapeutic Benefit. Moss, Alan; Bourke, Michael J.; Hourigan, Luke F.; Gupta, Saurabh; Williams, Stephen J.; Tran, Kayla; Swan, Michael P.; Hopper, Andrew D.; Kwan, Vu; Bailey, Adam A. // American Journal of Gastroenterology;Jun2010, Vol. 105 Issue 6, p1276 

    OBJECTIVES:Patients with Barrett's high-grade dysplasia (HGD) or early esophageal adenocarcinoma (EAC) that is shown on biopsy alone continue to undergo esophagectomy without more definitive histological staging. Endoscopic resection (ER) may provide more accurate histological grading and local...

  • Adenocarcinoma in Childhood Barrett's Esophagus: Case Documentation and the Need for Surveillance in Children. Hassall, Eric; Dimmick, James E.; Magee, J. Fergall // American Journal of Gastroenterology;Feb1993, Vol. 88 Issue 2, p282 

    A 17-yr-old boy underwent esophagectomy for multifocal high-grade dysplasia and adenocarcinoma complicating Barrett's esophagus (BE). He is believed to be the first child or young adult to have prolonged healthy survival following resection of esophageal adenocarcinoma. Dysplasia in a short...

  • Minimally invasive esophagectomy for Barrett's with high-grade dysplasia and early adenocarcinoma of the esophagus. Pennathur, Arjun; Awais, Omar; Luketich, James D. // Journal of Gastrointestinal Surgery;Jun2010, Vol. 14 Issue 6, p948 

    The article explores some aspects of applying minimally invasive esophagectomy for Barrett's with high grade dysplasia (HGD) and early adenocarcinoma of the esophagus. HGD refers to intraepithelial neoplasia that has not entered the basement membrane. Studies show that the incidence of occult...

  • Adenocarcinoma in Barrett Mucosa Treated by Endoscopic Mucosal Resection. Appelman, Henry D. // Archives of Pathology & Laboratory Medicine;Nov2009, Vol. 133 Issue 11, p1793 

    Adenocarcinoma and dysplasias are recognized complications of Barrett mucosa. In the past, the treatment for this carcinoma was esophagectomy. However, new techniques, including endoscopic mucosal resection, sometimes replace esophagectomy and are becoming standard procedures in clinical...

  • Salvage surgery feasible after chemoradiation for some esophageal adenocarcinomas. Harris, Jason // Hem/Onc Today;3/10/2009, Vol. 10 Issue 5, p30 

    The article discusses a retrospective study presented by physician Wayne L. Hofstetter, which found that some patients with esophageal adenocarcinoma who did not respond to definitive chemoradiation may still be eligible for salvage esophagectomy.

  • Esophagectomy for clinical high-grade dysplasia Rice, Thomas W.; Murthy, Sudish C.; Mason, David P.; Rybicki, Lisa A.; Yerian, Lisa M.; Dumot, John A.; Rodriguez, Cristina P.; Blackstone, Eugene H. // European Journal of Cardio-Thoracic Surgery;Jul2011, Vol. 40 Issue 1, p113 

    Abstract: Objective: Esophageal high-grade dysplasia/tumor in situ (HGD/Tis) management is in evolution. However, treatment decisions must be made on clinical staging, which may not reflect pathologic staging. Long-term randomized trial information, large treatment series, and cancer registry...

  • SSAT Controversies Intramucosal Esophageal Cancer and High-Grade Dysplasia: Which Treatment? Peters, Jeffrey H. // Journal of Gastrointestinal Surgery;Jul2009, Vol. 13 Issue 7, p1179 

    The article focuses on the treatment of Barrett's associated high-grade dysplasia (HGD). According to a study by C. Ell et al., endoscopic mucosal resection (EMR) was linked to low morbidity and no mortality and that the neoplastic focus has been removed over a 3-year time span. A study by E. E....

  • Endoscopic Management of Barrett's Esophagus: Advances in Endoscopic Techniques. Azarm, Ali; Lukolic, Ismet; Shukla, Meenal; Concha-Parra, Ronald; Gress, Frank // Digestive Diseases & Sciences;Dec2012, Vol. 57 Issue 12, p3055 

    Barrett's esophagus (BE) is a well-known premalignant condition that can be associated with the development of dysplasia and adenocarcinoma. In the past, esophagectomy was the standard treatment for patients with BE with high grade dysplasia (HGD) and early cancer (EC). However, esophagectomy is...

  • A Novel Esophageal-preserving Approach to Treat High-grade Dysplasia and Superficial Adenocarcinoma in the Presence of Chronic Gastroesophageal Reflux Disease. Hoppo, Toshitaka; Badylak, Stephen; Jobe, Blair // World Journal of Surgery;Oct2012, Vol. 36 Issue 10, p2390 

    Background: The optimal treatment strategy of esophageal high-grade dysplasia (HGD) and superficial adenocarcinoma remains controversial. Methods: Here, we describe endoscopic, circumferential mucosal-submucosal en-bloc resection of the entire abnormal esophageal epithelium with extracellular...


Read the Article


Sign out of this library

Other Topics